Loading organizations...
Loading organizations...

Float Health: A full-stack platform for specialty pharma, connecting nurses to patients for home infusion therapy for chronic illnesses
Float Health has raised $10.0M across 1 funding round.
Key people at Float Health.
Float Health was founded in 2021 by Ryan Johnson (Founder) and Christy Johnson (Founder).
Float Health has raised $10.0M in total across 1 funding round.
Based in Carlsbad, California, Float Health is a specialty pharmacy platform that connects skilled nurses with patients requiring home infusion therapy for chronic illnesses. The company operates a marketplace that manages scheduling, credentialing, clinical charting, and insurance invoicing to transition complex treatments from hospital settings to the homes of patients. Operating across eight states, the platform has facilitated more than 45,000 home visits and currently manages over 3,000 monthly appointments with a core team of just three full-time employees. Backed by Y Combinator and having raised $15 million in total funding, including a $10 million Series A in March 2024, the company serves major healthcare enterprises. Its network of over 100 pharmacy partnerships includes enterprise customers such as Optum, CVS, and Walgreens. Float Health was founded in 2021 by Ryan Johnson and Christy Johnson.
Float Health was founded in 2021 by Ryan Johnson (Founder) and Christy Johnson (Founder).
Float Health has raised $10.0M in total across 1 funding round.
Float Health's investors include Canvas Ventures, Atomic, Daffy, Davidovs VC, iNovia Capital, Kleiner Perkins, NFX, Phenomenal Ventures, SV Angel, Thirty Five Ventures, Arash Ferdowsi, Daniel Kan.
Key people at Float Health.
Float Health is a full-stack technology platform designed specifically for the Specialty Pharma sector, connecting highly skilled nurses ("SuperNurses") to deliver specialized medication treatments in patients' homes. The platform automates and streamlines home infusion care, making it safer, more efficient, and significantly more cost-effective compared to hospital-based care. Float serves specialty pharmacies by providing AI-powered nurse sourcing, scheduling, documentation, and reimbursement solutions, enabling pharmacies to reduce operational costs, improve patient adherence, and increase revenue. The platform has facilitated over 45,000 successful home medication visits and partners with more than 100 specialty pharmacies, including major industry players like CVS and Walgreens[1][2][5].
Founded in 2021 and part of Y Combinator’s Winter 2022 batch, Float Health was created to address the inefficiencies and access barriers in specialty medication delivery. The founder, Christy, brought a unique entrepreneurial background shaped by personal experiences with chronic illness in her family, inspiring a shift from hospital-centric care to home-based infusion therapy. Early traction came from demonstrating how AI-driven scheduling and nurse matching could reduce costs and administrative burdens while improving patient outcomes. The company has since evolved rapidly, expanding its geographic footprint and partnerships across multiple states[2][3].
Float Health is riding the significant healthcare trend of shifting routine specialty medication administration from hospitals to home settings. This transition is driven by rising healthcare costs, nursing shortages, and patient demand for convenient care. With specialty medications accounting for over half of pharmaceutical spending and home infusions expected to reach 20% of all infusions by 2027, Float’s timing is strategic. The company leverages AI and marketplace dynamics to address legacy hospital infrastructure inefficiencies and labor challenges, positioning itself as a key enabler of the home infusion care revolution. Its platform not only reduces costs but also improves medication adherence and patient outcomes, influencing the broader ecosystem of specialty pharmacies, payers, and healthcare providers[2][4][7].
Float Health is poised for continued growth as it expands its geographic reach and specialty pharmacy partnerships. Future trends shaping its journey include increasing adoption of home-based care models, advances in AI-driven healthcare logistics, and ongoing pressures to reduce healthcare costs. Float’s influence is likely to grow as it refines its platform capabilities, enhances nurse gig work opportunities, and deepens integration with specialty pharmacies’ workflows. By continuing to improve patient adherence and operational efficiency, Float can drive sustainable growth for its partners and play a pivotal role in transforming specialty pharmaceutical delivery nationwide[5][8].
Float Health has raised $10.0M across 1 funding round. Most recently, it raised $10.0M Series A in March 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2024 | $10.0M Series A | Canvas Ventures | Atomic, Daffy, Davidovs VC, iNovia Capital, Kleiner Perkins, NFX, Phenomenal Ventures, SV Angel, Thirty Five Ventures, Arash Ferdowsi, Daniel Kan, Max Mullen, Andrew Bartynski, Brian Osborn, Brian Pokorny, Jed Nachman, Also Capital, Burst Capital, Wave Capital, Y Combinator |